Skip Over Navigation Links
National Institutes of Health
Find more NIMH pages about: Medications

Science News about Medications

Find Press Releases and Science Updates by Topic

NIMH Study To Guide Treatment Choices for Schizophrenia (Phase 1 Results)
September 19, 2005 • Press Release
A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications
Actor-Patients´ Requests for Medications Boost Prescribing for Depression
April 27, 2005 • Press Release
Critics of direct-to-consumer marketing fear the advertisements lead to over-prescribing. Proponents believe they can serve a useful educational function.
New Neurons Born in Adult Rat Cortex
February 2, 2005 • Press Release
Recent evidence suggesting that antidepressants may act by triggering the birth of new neurons in the adult hippocampus the brain’s memory hub, has heightened interest in such adult neurogenesis and raised the question: Could new neurons also be sprouting up in the parts of the adult brain involved in the thinking and mood disturbances of depression and anxiety?
Mutant Gene Linked to Treatment-Resistant Depression
December 13, 2004 • Science Update
A mutant gene that starves the brain of serotonin, a mood-regulating chemical messenger, has been discovered and found to be 10 times more prevalent in depressed patients than in control subjects, report researchers funded by the National Institutes of Health’s National Institute of Mental Health (NIMH) and National Heart Lung and Blood Institute (NHLBI).
Psychotherapy, Medications Best for Youth With Obsessive Compulsive Disorder
October 28, 2004 • Press Release
Children and adolescents with Obsessive Compulsive Disorder (OCD) respond best to a combination of both psychotherapy and an antidepressant, a major clinical trial has found.
Combination Treatment Most Effective in Adolescents with Depression
August 17, 2004 • Press Release
A clinical trial of 439 adolescents with major depression has found a combination of medication and psychotherapy to be the most effective treatment.
Research to Test Treatment of Cognitive Dysfunction in Schizophrenia
May 6, 2004 • Press Release
The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).
“Care Managers” Help Depressed Elderly Reduce Suicidal Thoughts
March 2, 2004 • Press Release
An intervention that includes staffing doctors' offices with depression care managers helps depressed elderly patients reduce suicidal thoughts, a study funded by NIMH has found. Martha Bruce, Ph.D., Cornell University, Charles Reynolds, III, M.D., University of Pittsburgh, and colleagues report on the outcome of the intervention in three major Eastern U.S. metropolitan areas.
Creation of New Neurons Critical to Antidepressant Action in Mice
August 7, 2003 • Press Release
Blocking the formation of neurons in the hippocampus blocks the behavioral effects of antidepressants in mice, say researchers funded by the National Institutes of Health (NIH).
Medication and Psychotherapy Treat Depression in Low-Income Minority Women
July 1, 2003 • Press Release
Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH).
1 | 2 | 3 | 4 | 5 | 6 | 7 | Next >